Evidence map›Paper›PMID 29898954›Full record

ArticleEMBO reports2018

Mitofusin gain and loss of function drive pathogenesis in

Najla El Fissi, Manuel Rojo, Aїcha Aouane, Esra Karatas, Gabriela Poliacikova, Claudine David, Julien Royet, Thomas Rival

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Junctions in Jeopardy: the neuromuscular junction is a selective pathological target in Charcot-Marie-Tooth disease.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  3. Arginine ameliorates motor and survival deficits in MFN2-Deficient Drosophila models.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Modeling of Charcot-Marie-Tooth disease in zebrafish.Frontiers in molecular neuroscience · 2025
    Review
  9. Article
  10. Article
  11. Charcot-Marie-Tooth type 2A in vivo models: Current updates.Journal of cellular and molecular medicine · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. A nerve-wracking buzz: lessons fromFrontiers in aging neuroscience · 2023
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Najla El FissiAix Marseille University, CNRS, IBDM, Marseille, France.
Manuel RojoUniversity of Bordeaux, CNRS, Institut de Biochimie et Génétique Cellulaires (IBGC), UMR 5095, Bordeaux, France.
Aїcha AouaneAix Marseille University, CNRS, IBDM, Marseille, France.
Esra KaratasUniversity of Bordeaux, CNRS, Institut de Biochimie et Génétique Cellulaires (IBGC), UMR 5095, Bordeaux, France.
Gabriela PoliacikovaAix Marseille University, CNRS, IBDM, Marseille, France.
Claudine DavidUniversity of Bordeaux, CNRS, Institut de Biochimie et Génétique Cellulaires (IBGC), UMR 5095, Bordeaux, France.
Julien RoyetAix Marseille University, CNRS, IBDM, Marseille, France.
Thomas RivalAix Marseille University, CNRS, IBDM, Marseille, France thomas.rival@univ-amu.fr.ORCID 0000-0002-1324-2661
Centre National de la Recherche Scientifique · FR

Funding

Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5M
NIH HHS P40 OD018537
6 · The paper itself

Abstract

Charcot-Marie-Tooth disease type 2A (CMT2A) is caused by dominant alleles of the mitochondrial pro-fusion factor Mitofusin 2 (MFN2). To address the consequences of these mutations on mitofusin activity and neuronal function, we generate

Indexed as

AllelesAmino Acid SequenceAnimalsCharcot-Marie-Tooth DiseaseDisease Models, AnimalDrosophila melanogasterDrosophila ProteinsGain of Function MutationHumansLoss of Function MutationMembrane ProteinsMiceMitochondriaMitochondrial DynamicsMotor ActivityNeuromuscular JunctionDrosophila ProteinsMarf protein, DrosophilaMembrane ProteinsCMT2AMFN2mitochondrial fusionmitofusinperipheral neuropathy

Identifiers

PMID29898954
PMCPMC6073211
OpenAlexW2808596894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.